Call for experts to join WHO Technical Advisory Group (TAG) on Combination Vaccines

The World Health Organization (WHO) is seeking experts to serve as members on Technical Advisory Group on Combination Vaccines. Find out more below and apply by January 30, 2025.

The TAG on Combination Vaccines will include members with knowledge, skills and experience relevant to the identification, prioritization, assessment and development of combination vaccines. The experts should have scientific and technical expertise (such as immunology, antimicrobial resistance, epidemiology and burden estimates, vaccine development, clinical trials, health economics), or programmatic expertise (knowledge of opportunities, challenges and barriers to immunization in LMICs), or regulatory expertise.

The functions of the TAG on Combination Vaccines are as follows:

1. To advise WHO on the scientific, technical, and strategic aspects of combination vaccines, focusing on their potential public health impact, technical feasibility, and alignment with global immunization priorities.
2. To advise WHO on the development of a framework for evaluating and identifying priority combination vaccines, including the establishment of metrics and criteria for assessing their public health and economic value, particularly in low- and middle-income countries (LMICs).
3. To review and make recommendations to WHO on the programmatic and technical feasibility of specific vaccine combinations, ensuring that the proposed combinations are viable from both a technical and regulatory perspective and can be integrated into existing immunization schedules without significant barriers.
4. To advise WHO in strengthening links with regional immunization stakeholders, ensuring that regional input is integrated into the development of combination vaccines, and that the translation of global priorities into actionable regional strategies, ensuring that combination vaccines meet the specific needs and contexts of different regions.
5. To support WHO in developing communication strategies that highlight the importance and benefits of combination vaccines, helping to build consensus among policymakers, donors, and other stakeholders.